STOCK TITAN

Daniel Kaufman reports 5.08% stake in Delcath Systems (DCTH)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Delcath Systems, Inc. ownership filing shows Daniel Kaufman reports beneficial ownership of 1,766,432 shares of Common Stock, representing 5.08% of the class as reported on 03/18/2026. The filing is a Schedule 13G disclosure of an equity stake by an individual investor.

Positive

  • None.

Negative

  • None.

Insights

Stake disclosure: individual investor holds a meaningful passive stake.

Daniel Kaufman reports 1,766,432 shares, or 5.08%, of common stock. The filing format is a Schedule 13G, which typically indicates a passive investment intent rather than an activist or control-seeking position.

Key dependencies include whether the position is passive and whether subsequent filings alter ownership; subsequent Form 13D would indicate a change in intent.

Disclosure affects ownership transparency and reporting thresholds.

The reported 5.08% crosses common SEC reporting thresholds that require public disclosure of beneficial ownership. This provides market participants with visibility into substantial individual holdings in the issuer.

Any material change in voting or disposition powers, or a shift from passive to active intent, would normally trigger a different filing form.






24661P807

(CUSIP Number)
03/18/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Daniel Kaufman
Signature:/s/ Daniel Kaufman
Name/Title:Daniel Kaufman, Individual Investor
Date:03/20/2026
Exhibit Information

None

FAQ

What stake does Daniel Kaufman report in Delcath (DCTH)?

Daniel Kaufman reports beneficial ownership of 1,766,432 shares, equal to 5.08% of Delcath's common stock as stated in the Schedule 13G filing dated 03/18/2026. The disclosure is presented as a passive ownership report.

Does the Schedule 13G filing indicate activist intent for DCTH?

A Schedule 13G filing typically indicates a passive investment intent rather than activist action. The filing identifies the investor and stake (1,766,432 shares, 5.08%) but does not state plans to influence management or control.

What voting and dispositive powers does Kaufman report for DCTH shares?

The filing states Kaufman has sole voting power of 1,766,432 shares and sole dispositive power of 1,766,432 shares. No shared voting or dispositive powers are reported in the Schedule 13G excerpt provided.

When was the beneficial ownership reported for Delcath (DCTH)?

The Schedule 13G shows the CUSIP and an ownership statement tied to 03/18/2026, with the filing signature dated 03/20/2026. The reported stake is 1,766,432 shares representing 5.08% of the class.
Delcath Sys

NASDAQ:DCTH

View DCTH Stock Overview

DCTH Rankings

DCTH Latest News

DCTH Latest SEC Filings

DCTH Stock Data

324.53M
33.68M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
QUEENSBURY